Overview

Azilsartan Circadian and Sleep Pressure

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

To determine the efficacy of Azilsartan 20 mg versus Amlodipine 5 mg oral administration once per day for 8 weeks in patients with grade I or grade II essential hypertension.

Phase:

N/A

Details

Lead Sponsor:

Sogo Rinsho Médéfi Co., Ltd.

Collaborator:

Takeda

Treatments:

Amlodipine
Azilsartan medoxomil